Consensus statement: Role of therapy with "statins" in patients with hypertriglyceridemia.
Grundy
S M
SM
Department of Clinical Nutrition, Center for Human Nutrition, University of Texas Southwestern Medical Center at Dallas, 75235-9052, USA.
D008076:Cholesterol, HDL / Q000097:blood; D015243:Cholesterol, VLDL / Q000097:blood; D002986:Clinical Trials as Topic; D003245:Consensus Statements as Topic; D003327:Coronary Disease / Q000209:etiology / Q000517:prevention & control; D004359:Drug Therapy, Combination; D015444:Exercise; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D015228:Hypertriglyceridemia / Q000097:blood / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000008:administration & dosage*; D008074:Lipoproteins / Q000378:metabolism; D008148:Lovastatin / Q000008:administration & dosage*; D009525:Niacin / Q000008:administration & dosage; D017035:Pravastatin / Q000008:administration & dosage*; D012307:Risk Factors; D019821:Simvastatin / Q000008:administration & dosage; D014280:Triglycerides / Q000097:blood; D015431:Weight Loss
D008076:Cholesterol, HDL; D015243:Cholesterol, VLDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D008074:Lipoproteins; D014280:Triglycerides; D009525:Niacin; D008148:Lovastatin; D019821:Simvastatin; D017035:Pravastatin